DOT1 histone methyltransferases as a target for identifying therapeutic agents for leukemia
View Patent ↗The present invention provides polypeptides with histone H3 lysine 79 methyltransferase activity as well as nucleic acids encoding the same. Also provided are methods of using the polypeptides and nucleic acids of the invention in screening assays to identify compounds of interest. Further provided are diagnostic methods for leukemia and prognostic methods to predict the course of the disease in a subject.
1. An isolated cDNA encoding a DOT1L polypeptide, said cDNA selected from the group consisting of:
(a) a cDNA comprising SEQ ID NO:1;
(b) a cDNA comprising the nucleotide sequence that encodes the DOT1L polypeptide of SEQ ID NO:2;
(c) a cDNA that differs from the nucleotide sequence of (a) due to the degeneracy of the genetic code;
(d) a cDNA consisting of a fragment of SEQ ID NO:1, wherein said fragment consists of a nucleotide sequence that encodes amino acids 1 to 416 of SEQ ID NO:2;
(e) a cDNA consisting of a nucleotide sequence that has at least 95% sequence similarity to the cDNA of (d), wherein said cDNA encodes a polypeptide having H3-K79 methyltransferase activity; and
(f) a cDNA consisting of a nucleotide sequence that differs from the nucleotide sequence of (d) due to the degeneracy of the genetic code, wherein said cDNA encodes a polypeptide having H3-K79 methyltransferase activity.
2. The isolated cDNA of claim 1 , wherein the cDNA encodes the DOT1L polypeptide of SEQ ID NO:2.
3. The isolated cDNA of claim 1 , wherein the cDNA comprises SEQ ID NO:1.
4. The isolated cDNA of claim 1 , wherein the cDNA consists of SEQ ID NO:1.
5. The isolated cDNA of claim 1 , wherein the cDNA encodes a DOT1L fusion protein.
6. A vector comprising the isolated cDNA of claim 1 .
7. The vector of claim 6 , wherein the vector is an expression vector.
8. An isolated cell comprising the isolated cDNA of claim 1 .
9. An isolated cell comprising the vector of claim 6 .
10. A method of producing a DOT1L polypeptide, comprising culturing the cell of claim 8 in vitro such that the DOT1L polypeptide is expressed from said cDNA encoding the DOT1L polypeptide.
11. An expression vector comprising a cDNA encoding a DOT1L polypeptide having histone H3 lysine 79 (H3-K79) methyltransferase activity, wherein the cDNA (a) consists of SEQ ID NO:1; or (b) consists of a nucleotide sequence that has at least 97% nucleotide sequence similarity with SEQ ID NO:1, wherein said cDNA encodes a polypeptide having H3-K79 methyltransferase activity.
12. An isolated cell comprising the expression vector of claim 11 .
13. A method of producing a DOT1L polypeptide, comprising culturing the cell of claim 12 in vitro such that the DOT1L polypeptide is expressed from said cDNA encoding the DOT1L polypeptide.